[1] 朱健铭,刘国庆,姜如金,等. 多药耐药肺炎克雷伯菌β-内酰胺类耐药机制研究[J] . 中华医院感染学杂志,2012,22(4):674-678.
[2] Wei ZQ, Du XX, Yu YS, et al. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China[J] . Antimicrob Agents Chemother,2007,51(2):763-765.
[3] 冯雅君,沈 萍,杜小幸,等. 产碳青霉烯酶KPC-2肺炎克雷伯菌局部流行[J] . 浙江医学,2008,30(9):923-925.
[4] Qi Y, Wei Z, Ji S, et al. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China[J] . J Antimicrob Chemother,2010,66(2):307-312.
[5] Kitchel B,Rasheed JK,Patel JB,et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258[J] . Antimicrob Agents Chemother,2009,53(8):3365-3370.
[6] Giakkoupi P,Papagiannitsis CC,Miriagou V,et al. An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece(2009-10)[J] . J Antimicrob Chemother,2011,66(7):1510-1513.